Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus (L04Ah01) As Part Of A So-Called Open House Model.
Deadline - Apr 30, 2026
GT reference number - 81987430
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 81987430
Document Type - Tender Notices
Description - Description: Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for drugs with the active ingredient sirolimus (L04AH01) within the period from July 1st, 2024 to June 30th, 2026 with the possibility of concluding a contract at any time (open-house model ). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (children's medicines) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sirolimus (L04AH01) Rahmen eines sogenannten Open-House-Modells.type_of_procedure: Otherbidding_respon
Gt Ref Id - 81987430
Deadline - Apr 30, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database